Slough, United Kingdom

James Philip O'Connell

This inventor holds 10 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Ucbbiopharma Srl, Sanofi. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Philip O'Connell. Retrieved from https://idiyas.com/inventor/james-philip-o-connell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Slough Berkshire, GB (2020)
  • Slough, GB (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of James Philip O'Connell

Introduction

James Philip O'Connell is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of nine patents to his name, O'Connell's work has the potential to impact various medical treatments.

Latest Patents

O'Connell's latest patents include innovative methods related to anti-TNFα antibodies. One of his patents demonstrates that certain compounds can bind to TNF and stabilize a conformation of trimeric TNF that binds to the TNF receptor. This discovery allows for the development of antibodies that selectively bind to complexes of these compounds with TNF superfamily members. These antibodies may be utilized to detect further compounds with similar activity and serve as target engagement biomarkers. Another significant patent involves a method for identifying potential inhibitors of APO TNFα trimers. This patent discloses a new, stable trimeric TNFα structure with distorted symmetry that can bind to the TNFR1 receptor, attenuating signaling and potentially aiding in the treatment and prevention of diseases associated with the soluble TNFα/TNFR1 interaction.

Career Highlights

Throughout his career, O'Connell has worked with prominent companies in the pharmaceutical industry, including UCB Biopharma and Sanofi. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

O'Connell has collaborated with esteemed colleagues such as John Robert Porter and Alastair Lawson. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

James Philip O'Connell's innovative work in the field of biotechnology, particularly in the area of therapeutic antibodies, showcases his significant contributions to medical science. His patents reflect a commitment to advancing treatment options for various diseases, highlighting the importance of his research in the ongoing quest for medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…